טוען...
Overview of recent advances in metastatic triple negative breast cancer
Metastatic triple negative breast cancer (TNBC) has an aggressive phenotype with a predilection for visceral organs and brain. Best responses to chemotherapy are predominately in the first line. Recent studies have demonstrated improved progression free survival with the combination of atezolizumab/...
שמור ב:
| הוצא לאור ב: | World J Clin Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968109/ https://ncbi.nlm.nih.gov/pubmed/33767972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v12.i3.164 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|